News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Supreme Court struck down major IEEPA-backed tariffs, removing roughly half of the U.S. tariff framework and easing importers' cost pressure.
  • President Trump imposed a temporary 10% duty on all imports, reintroducing trade-policy uncertainty for global markets.
  • European and Asian exporters are recalibrating trade and investment plans after the tariff reversal and new 10% duty.
  • UBS raised its gold target to $6,200, signaling stronger safe-haven demand and upside pressure on gold prices.
  • UBS highlighted Walmart's strong Q4 and higher-margin digital layers as supportive of earnings revisions and the stock's valuation.
  • W.P. Carey offers about a 5% yield with strong coverage, pitched as a mid- to long-term income buy for yield investors.
  • OneSpan is presented as a mid-term defensive growth buy on solid free cash flow and low leverage.

Latest Articles

HSBC Lowers TechnipFMC to Hold but Increases Price Target to $62

HSBC Lowers TechnipFMC to Hold but Increases Price Target to $62

HSBC moved TechnipFMC from Buy to Hold while raising its 12-month price target to $62 from $49. The change follows a set of mixed quarterly and strong annual results: fourth-quarter revenue and margins dipped sequentially, but full-year 2025 revenue and adjusted EBITDA margins improved. Share repurchases slowed in the quarter despite a new $2 billi…

Chemring Upholds FY26 Guidance as Order Cover Climbs to 85%

Chemring Upholds FY26 Guidance as Order Cover Climbs to 85%

Chemring Group PLC has maintained its FY26 guidance as of the end of January 2026, reporting a modest increase in its order book and a rise in group order cover to 85%. While total orders advanced slightly to £1.364bn, first-quarter order intake dropped to £122m, reflecting the absence of the multi-year contracts that lifted Q1 2025 results. Divisi…

ALK-Abello Posts Q4 Beats, Proposes First Dividend Since 2017

ALK-Abello Posts Q4 Beats, Proposes First Dividend Since 2017

ALK-Abello reported fourth quarter sales and operating profit above consensus, driven by stronger-than-expected European tablet sales and Other Products. The Danish biotechnology firm proposed a DKK1.6 per share dividend, its first since 2017, and issued 2026 revenue and margin guidance while confirming leadership changes in research and developmen…

Equitable Holdings CEO Sells $1.8M in Stock Ahead of Notable Revenue Miss

Equitable Holdings CEO Sells $1.8M in Stock Ahead of Notable Revenue Miss

Equitable Holdings President and CEO Mark Pearson sold 39,700 shares on February 18, 2026, for about $1.8 million while also exercising options to acquire 27,200 shares at $23.18. The stock is trading below recent highs and InvestingPro flags the equity as appearing overvalued. Separately, Equitable reported Q4 2025 EPS in line with expectations bu…

FDA Clears All-Oral Calquence and Venetoclax Regimen for CLL and SLL

FDA Clears All-Oral Calquence and Venetoclax Regimen for CLL and SLL

The U.S. Food and Drug Administration has approved AstraZeneca’s Calquence (acalabrutinib) in combination with venetoclax as the first all-oral, fixed-duration regimen for adults with chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). The decision is grounded in results from the AMPLIFY Phase III trial, which demonstrated hig…

Gentex VP Disposes Nearly $500k in Stock While Retaining Substantial Stake

Gentex VP Disposes Nearly $500k in Stock While Retaining Substantial Stake

Gentex Vice President of Sales Matthew Chiodo sold 19,827 shares on February 17, 2026, for about $496,170, while also recording zero-price acquisitions and tax-related share withholdings in filings with the SEC. The transactions leave Chiodo with 47,148 shares. Separately, Gentex posted a slight EPS beat but a marginal revenue shortfall for Q4 2025…

Tokyo stocks retreat as Nikkei 225 falls 1.07% at Friday close

Tokyo stocks retreat as Nikkei 225 falls 1.07% at Friday close

Tokyo’s Nikkei 225 slipped 1.07% at Friday’s close as losses concentrated in Paper & Pulp, Transport and Communication stocks outpaced gains. Mitsui Mining and Smelting, IHI Corp. and Sumitomo Electric Industries were among the session’s top advancers, while Sumitomo Dainippon Pharma, Olympus and Seven & i Holdings recorded the day’s steepest decli…

Robinhood CFO Disposes $411k in Stock; Holds 51,771 Shares After Sale

Robinhood CFO Disposes $411k in Stock; Holds 51,771 Shares After Sale

Robinhood Markets Inc CFO Shiv Verma sold 5,474 shares of Class A common stock on February 17, 2026, collecting roughly $411,273 in proceeds. The trades, carried out at prices between $73.444 and $76.3638, left Verma with direct ownership of 51,771 shares. The transaction occurred under a Rule 10b5-1 trading plan adopted in August 2025 amid a perio…

Commerce.com Executive Chair Purchases $294,080 in Series 1 Shares

Commerce.com Executive Chair Purchases $294,080 in Series 1 Shares

Commerce.com Executive Chair Ellen F. Siminoff bought 100,000 shares of the company’s Series 1 Common Stock on February 17, 2026, paying between $2.905 and $2.99 per share for a total of $294,080. The purchase comes while the stock trades near its 52-week low and follows recent corporate integrations with Stripe and analyst downgrades and price-tar…